Genprex GNPX Stock News

Today has been an active day in the stock market. In case you missed it, here are the biggest stories of the day so far:

The Veritas Farms (OTCMKTS: VFRM) opportunity is growing. Not only is the company executing on big-box placements, it is expanding production abilities in a big way! Read the full story here.

Genprex (NASDAQ: GNPX) is becoming a very serious opportunity, with a leader that has a personal vendetta against cancer. Learn more here!

Seelos Therapeutics (NASDAQ: SEEL) is having a strong day in the market after acquiring a new gene therapy asset with tremendous potential. Check out the story!

Cemtrex (NASDAQ: CETX) is climbing after announcing serious growth in its contractual backlog. Here’s the scoop!

Atossa Genetics (NASDAQ: ATOS) announced positive clinical data, setting the stage for a pivotal trial and a potential entrance into a large market. Here’s what you need to know!

Finally, Dova Pharmaceuticals (NASDAQ: DOVA) announced a regulatory approval in Europe, opening the door to a serious market opportunity! Here’s the story!

CNA Finance, parent company to Alpha Stock News, has been paid to cover Genprex news.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.